Maha Assi

2.6k total citations · 1 hit paper
36 papers, 1.4k citations indexed

About

Maha Assi is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Maha Assi has authored 36 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Infectious Diseases, 24 papers in Epidemiology and 7 papers in Surgery. Recurrent topics in Maha Assi's work include Antifungal resistance and susceptibility (13 papers), Fungal Infections and Studies (13 papers) and Cytomegalovirus and herpesvirus research (6 papers). Maha Assi is often cited by papers focused on Antifungal resistance and susceptibility (13 papers), Fungal Infections and Studies (13 papers) and Cytomegalovirus and herpesvirus research (6 papers). Maha Assi collaborates with scholars based in United States, Canada and Lebanon. Maha Assi's co-authors include Rachel Miller, Mohamad S. Sandid, Randall C. Walker, Larry M. Baddour, Glenn D. Roberts, Nancy L. Wengenack, Chadi A. Hage, L. Joseph Wheat, Julie A. Ribes and T. E. Davis and has published in prestigious journals such as Gastroenterology, Clinical Infectious Diseases and Journal of Clinical Microbiology.

In The Last Decade

Maha Assi

33 papers receiving 1.4k citations

Hit Papers

Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III,... 2022 2026 2023 2024 2022 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maha Assi United States 17 1.1k 852 174 114 110 36 1.4k
Dino Sgarabotto Italy 14 839 0.8× 347 0.4× 124 0.7× 57 0.5× 206 1.9× 45 1.2k
Estela Giménez Spain 22 846 0.8× 516 0.6× 86 0.5× 70 0.6× 297 2.7× 117 1.4k
Yolanda Meije Spain 19 761 0.7× 669 0.8× 222 1.3× 64 0.6× 70 0.6× 34 1.1k
Nicolas C. Issa United States 18 551 0.5× 307 0.4× 186 1.1× 42 0.4× 183 1.7× 57 978
Jayant Kalpoe Netherlands 17 705 0.6× 240 0.3× 63 0.4× 86 0.8× 223 2.0× 31 1.1k
Michael Boeckh United States 15 1.2k 1.1× 794 0.9× 121 0.7× 44 0.4× 322 2.9× 33 1.5k
Victor H. Ferreira Canada 20 437 0.4× 546 0.6× 111 0.6× 127 1.1× 86 0.8× 59 1.3k
James Flexman Australia 21 803 0.7× 577 0.7× 264 1.5× 87 0.8× 123 1.1× 57 1.6k
Ana García‐Reyne Spain 17 467 0.4× 261 0.3× 131 0.8× 34 0.3× 88 0.8× 29 805
C. Orla Morrissey Australia 23 1.3k 1.2× 1.2k 1.4× 77 0.4× 115 1.0× 240 2.2× 67 1.7k

Countries citing papers authored by Maha Assi

Since Specialization
Citations

This map shows the geographic impact of Maha Assi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maha Assi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maha Assi more than expected).

Fields of papers citing papers by Maha Assi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maha Assi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maha Assi. The network helps show where Maha Assi may publish in the future.

Co-authorship network of co-authors of Maha Assi

This figure shows the co-authorship network connecting the top 25 collaborators of Maha Assi. A scholar is included among the top collaborators of Maha Assi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maha Assi. Maha Assi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khanna, Sahil, Maha Assi, Christine Lee, et al.. (2022). Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection. Drugs. 82(15). 1527–1538. 179 indexed citations breakdown →
2.
Hayat, Umar, Muhammad Ashfaq, Luke Johnson, et al.. (2022). The Association of Metabolic-associated Fatty Liver Disease with Clinical Outcomes of COVID-19: A Systematic Review and Meta-Analysis. Kansas Journal of Medicine. 15(2). 241–246. 15 indexed citations
3.
Assi, Maha, et al.. (2021). A Case of Actinomycosis Presenting as Purulent Pericarditis with Cardiac Tamponade. Kansas Journal of Medicine. 14. 227–228.
5.
Ablah, Elizabeth, et al.. (2019). Contribution of the BioFire® FilmArray® Meningitis/Encephalitis Panel:. Kansas Journal of Medicine. 12(1). 1–3. 20 indexed citations
6.
Assi, Maha, et al.. (2018). Gastrointestinal histoplasmosis ileal stricture successfully treated with through-the-scope balloon dilation in a patient with hyperimmunoglobulin M syndrome. Clinical Journal of Gastroenterology. 11(3). 224–228. 3 indexed citations
7.
Vergidis, Paschalis, Raymund R. Razonable, L. Joseph Wheat, et al.. (2014). Reduction in False-Positive Aspergillus Serum Galactomannan Enzyme Immunoassay Results Associated with Use of Piperacillin-Tazobactam in the United States. Journal of Clinical Microbiology. 52(6). 2199–2201. 46 indexed citations
8.
Riddell, James, Carol A. Kauffman, Jeannina A. Smith, et al.. (2014). Histoplasma capsulatum Endocarditis. Medicine. 93(5). 186–193. 35 indexed citations
9.
Miller, Rachel & Maha Assi. (2013). Endemic Fungal Infections in Solid Organ Transplantation. American Journal of Transplantation. 13. 250–261. 41 indexed citations
10.
Assi, Maha, et al.. (2011). Cross-Reactivity in the Histoplasma Antigen Enzyme Immunoassay Caused by Sporotrichosis. Clinical and Vaccine Immunology. 18(10). 1781–1782. 33 indexed citations
11.
Hage, Chadi A., Julie A. Ribes, Nancy L. Wengenack, et al.. (2011). A Multicenter Evaluation of Tests for Diagnosis of Histoplasmosis. Clinical Infectious Diseases. 53(5). 448–454. 248 indexed citations
12.
Assi, Maha, Mohamad S. Sandid, Larry M. Baddour, Glenn D. Roberts, & Randall C. Walker. (2010). Risk factor analysis ofHistoplasma capsulatumfungemia. Medical Mycology. 48(1). 85–89. 9 indexed citations
13.
Fakih, Riad El, Thomas A. Moore, & Maha Assi. (2008). Sinusitis And Orbital Cellulitis Due To Community-Associated Methicillin-Resistant Staphylococcus Aureus. Kansas Journal of Medicine. 1(4). 85–88. 1 indexed citations
14.
Fakih, Riad El, et al.. (2008). Unusual presentation of Ramsay Hunt syndrome in renal transplant patients: case report and literature review. Transplant Infectious Disease. 11(1). 72–74. 11 indexed citations
15.
Assi, Maha, Mohamad S. Sandid, Larry M. Baddour, Glenn D. Roberts, & Randall C. Walker. (2007). Systemic Histoplasmosis. Medicine. 86(3). 162–169. 151 indexed citations
16.
Assi, Maha, Jon E. Rosenblatt, & W.F. Marshall. (2007). Donor‐transmitted toxoplasmosis in liver transplant recipients: a case report and literature review. Transplant Infectious Disease. 9(2). 132–136. 20 indexed citations
17.
Assi, Maha, Joseph D. Yao, & Randall C. Walker. (2007). Lyme disease followed by human granulocytic anaplasmosis in a kidney transplant recipient. Transplant Infectious Disease. 9(1). 66–72. 9 indexed citations
18.
Perri, Roman, Maha Assi, Jayant A. Talwalkar, et al.. (2007). Graft vs. host disease after liver transplantation: A new approach is needed. Liver Transplantation. 13(8). 1092–1099. 64 indexed citations
19.
Assi, Maha, José S. Pulido, Steve G. Peters, Colin A. McCannel, & Raymund R. Razonable. (2006). Graft‐vs.‐host disease in lung and other solid organ transplant recipients. Clinical Transplantation. 21(1). 1–6. 35 indexed citations
20.
Sandid, Mohamad S., Maha Assi, & Sandra Hall. (2006). Intraoperative hypotension and prolonged operative time as risk factors for slow graft function in kidney transplant recipients. Clinical Transplantation. 20(6). 762–768. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026